J. Almond

European Adjuvant Trials

M. Büchler, J. Neoptolemos, C. Bassi, 2002 .

European Study Group for Pancreatic Cancer‐1 interim results: a European randomized study to assess the roles of adjuvant chemotherapy and chemoradiation in resectable pancreatic cancer

D. Kerr, H. Friess, J. Neoptolemos, 2001 .

ESPAC-1: A European, randomised study to assess the roles of adjuvant chemotherapy and chemoradiation in resectable pancreatic cancer

D. Kerr, J. Neoptolemos, C. Bassi, 2001 .

Identification of novel expressed sequences, up‐regulated in the leucocytes of chronic fatigue syndrome patients

G Lewith, G. Lewith, R Powell, 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial

D. Kerr, H. Friess, J. Neoptolemos, 2001, The Lancet.

The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer

J. Almond, S. Ralston, 2007, British Journal of Cancer.

New frontiers for cardiac risk assessment: C-reactive protein.

J. Almond, C. Martin, 2006, The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists.

Influence of Resection Margins on Survival for Patients With Pancreatic Cancer Treated by Adjuvant Chemoradiation and/or Chemotherapy in the ESPAC-1 Randomized Controlled Trial

I Ihse, R Sutton, D. Kerr, 2001, Annals of surgery.